← Leaderboards
Duncan L McVey
Genvec, Inc.
$3,069,048
Attributed
$3,069,048
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $899.3K · FY2005–11$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$3,069,048 · 2
By mechanism
R44$2,470,960 · 1
R43$598,088 · 1
Top collaborators
No co-investigators on record.
Most similar at Genvec, Inc.
Same institution · by research overlap
- Joseph T Bruder$2,184,286
- Jason Graham Gall$1,689,371
- C. Richter King$1,667,266
- Lisa L Wei$1,941,075
- Douglas E. Brough$697,273
Others in their field
Top investigators on “Vector Vaccine”
- Lawrence Corey · Fred Hutchinson Cancer Center$446,547,761
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$239,426,049
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$142,420,923
- Peter B. Gilbert · Fred Hutchinson Cancer Center$124,587,333
- Louis J. Picker · Oregon Health And Science University$70,366,260
- David Heimbrook · Leidos Biomedical Research, Inc.$68,561,099
Research focus
Vector VaccineAdenovirus VectorAnimalsAntigensApplications GrantsAreaBacteriaBaseCell LineCellsCostDesignEnsureEpigenetic ProcessFoot-And-Mouth DiseaseFutureGenesHuman DiseaseMalariaMoldsPreventProductionPromotor (Genetics)Adenoviruses
Grant awards (5)
Production of Adenovector Based Vaccines$899,329
R44 · FY2011 · AI · contact PI
Production of Adenovector Based Vaccines$886,735
R44 · FY2010 · AI · contact PI
Production of Adenovector Based Vaccines$684,896
R44 · FY2009 · AI · contact PI
Production of Adenovector Based Vaccines$298,330
R43 · FY2006 · AI · contact PI
Production of Adenovector Based Vaccines$299,758
R43 · FY2005 · AI